Expert Voices in Dementia
Thought leaders from the field present insights from dementia research, clinical practice, and caregiving that will help you maximize the quality of life and well-being of your patients
Episodes
May 1, 2025 • 17 mins
In this episode, we are joined by entrepreneur and television personality, Barbara Corcoran. While many know Barbara for her business acumen and dynamic presence on Shark Tank, fewer may know the deeply personal and powerful story she shares today—her nine-year journey as a caregiver for her mother, who lived with Alzheimer disease.
In this heartfelt conversation, Barbara opens up about the early signs her family overlooked, the ...
Mark as Played
March 21, 2025 • 20 mins
Sterling Johnson, PhD, Associate Director and Biomarker Core Leader in the Wisconsin Alzheimer’s Disease Research Center (ADRC), and a Clinical Neuropsychologist and Neuroscientist focused on understanding AD-related changes in the brain, details his research into the use of plasma p-tau217 as a blood-based biomarker for detecting Alzheimer disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
Nicolas Villain, MD, PhD, Associate Professor of Neurology, Sorbonne University, Paris, France, discusses the International Working Group’s updated diagnostic criteria for the diagnosis and staging of Alzheimer disease, which offer an alternative definitional view of AD as a clinical-biologic construct.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
January 25, 2025 • 16 mins
Timo Grimmer, MD, Associate Professor of Psychiatry and Psychotherapy and Head of the Centre for Cognitive Disorders at the Technical University of Munich, Germany, discusses the experimental oral small molecule drug blarcamesine, which is under investigation as a potential treatment for Alzheimer disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
December 19, 2024 • 10 mins
Sarena Ho, Health Insurance Specialist at the CMS Innovation Center, provides an overview on the Guiding an Improved Dementia Experience (GUIDE) Model, which helps physicians provide coordinated care to support patients with dementia and their caregivers.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 19, 2024 • 15 mins
Gary E. Gibson, PhD, Professor of Neurosciences, Burke Neurological Institute, Weill Cornell Medicine, White Plains, NY, details his research related to metabolic changes associated with Alzheimer disease and a clinical trial studying the effects of benfotiamine therapy on cognitive and other outcomes.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
November 8, 2024 • 7 mins
Kim Rodriguez, CEO of BrainCheck, provides an overview of the company's cognitive assessment plan and how clinicians can use these tools in practice.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
September 27, 2024 • 12 mins
Lynn D. Kramer, MD, FAAN, Chief Clinical Officer, Deep Human Biology Learning at Eisai and a member of the Eisai Executive Committee, and Christopher van Dyck, MD, Professor of Psychiatry, Neurology, and Neuroscience, Yale School of Medicine, provide an overview of key results from the Clarity AD clinical trial assessing the safety and efficacy of lecanemab in people with early Alzheimer disease presented at the 2024 Alzheimer's As...
Mark as Played
September 21, 2024 • 10 mins
In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler provides advice for physicians ...
Mark as Played
September 21, 2024 • 17 mins
In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler presents an overview of factors...
Mark as Played
September 21, 2024 • 8 mins
In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler discusses key factors physician...
Mark as Played
September 16, 2024 • 12 mins
Joseph M. Volpe, MD, Discipline Director, Clinical Neuroscience, Labcorp, discusses biomarker testing for Alzheimer disease and dementia,, including current offerings, reimbursement, and future directions in this evolving area.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
July 19, 2024 • 20 mins
Dan Morhaim, MD, board-certified emergency medicine and internal medicine physician, and former 24-year Maryland State Legislator, highlights the importance of discussing end-of-life care issues with dementia patients and best practices for physicians to follow when broaching this topic.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
July 15, 2024 • 22 mins
Virginia Man-Yee Lee, PhD, who serves as the John H. Ware 3rd Endowed Professor in Alzheimer's Research at the University of Pennsylvania Perelman School of Medicine, the Director of the Center for Neurodegenerative Disease Research, and Co-Director of the Marian S. Ware Center for Alzheimer's Drug Discovery, presents an overview of tau biomarker testing and research.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
July 15, 2024 • 9 mins
Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss new findings on baseline characteristics about amyloid-related imaging abnormalities (ARIA) in people with Alzheimer disease treated with donanemab.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
Dawn Brooks, PhD, Global Development Leader, Eli Lilly and Company, and John Sims, MD, Senior Medical Director, Eli Lilly and Company, discuss recent data analyzing the real-world implications of donanemab treatment for people with Alzheimer disease.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
July 15, 2024 • 14 mins
Howard Fillit, MD, geriatrician, neuroscientist, and Chief Science Officer and Co-Founder of the Alzheimer's Drug Discovery Foundation, discusses the importance of research into new therapeutic targets to develop next-generation treatments for Alzheimer disease, including small molecule compounds.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
George Grossberg, MD, Samuel W. Fordyce Professor and Director of Geriatric Psychiatry, Saint Louis University School of Medicine, provides an overview of recent progress in the evaluation, diagnosis, and treatment of neuropsychiatric symptoms in people living with dementia, including nonpharmacologic and pharmacologic interventions.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
July 7, 2024 • 18 mins
Dementia care expert, gerontologist, and author, Laura Wayman provides insights into what caregivers for people living with dementia need from healthcare providers and how clinicians can best partner with caregivers.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played
Popular Podcasts
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The official podcast of comedian Joe Rogan.
The latest news in 4 minutes updated every hour, every day.
The World's Most Dangerous Morning Show, The Breakfast Club, With DJ Envy And Charlamagne Tha God!
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com